On May 20, local time, the American online medical company Hims & Hers Health announced that it will launch a simeglutide complex. The starting price is $199 per month, which is about 85% lower than the original sales price of Novo and NORD's original research drugs. Wegovy (injectable weight loss drug) sells for at least $1,350 per month, and Ozempic (injectable hypoglycemic drug) also costs more than $900. Novo Nordisk said in response to the interview that Novo Nordisk is the only company that has drugs containing simeglutide approved by the US Food and Drug Administration (FDA). The US FDA has not approved any simeglutide bioanalogues. Any telemedicine service provider and dispensing pharmacy that claims to provide or sell unapproved products containing “simeglutide formulations” is derived from Fennol and Nord. (Times Finance)
美国药房将上架司美格鲁肽平替版，诺和诺德：没有授权其他人生产
US pharmacies will launch a replacement version of simeglutide. Novo Nordisk: No one else is authorized to produce it
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.